Efficacy and safety of atorvastatin in the treatment of hypercholesterolemia associated with antiretroviral therapy

被引：27

作者：

Palacios, R ^{[2
]}

Santos, J

González, M

Ruiz, J

Valdivielso, P

Márquez, M

González-Santos, P

机构：

[1] Univ Malaga, Dept Med, E-29071 Malaga, Spain

[2] Hosp Virgen de la Victoria, Internal Med Serv, Infect Dis Unit, Malaga, Spain

[3] Hosp Virgen de la Victoria, Internal Med Serv, Lipid Unit, Malaga, Spain

来源：

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2002年 / 30卷 / 05期

关键词：

D O I：

10.1097/00126334-200208150-00012

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：536 / 537

页数：2

共 15 条

[1] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].

Carr, A ;

Samaras, K ;

Burton, S ;

Law, M ;

Freund, J ;

Chisholm, DJ ;

Cooper, DA .

AIDS, 1998, 12 (07) :F51-F58

[2] Adverse effects of antiretroviral therapy [J].

Carr, A ;

Cooper, DA .

LANCET, 2000, 356 (9239) :1423-1430

[3]

Castelli WP, 1996, ATHEROSCLEROSIS, V124, pS1, DOI 10.1016/0021-9150(96)05851-0

[4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[5] Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047 [J].

Fichtenbaum, CJ ;

Gerber, JG ;

Rosenkranz, SL ;

Segal, Y ;

Aberg, JA ;

Blaschke, T ;

Alston, B ;

Fang, F ;

Kosel, B ;

Aweeka, F .

AIDS, 2002, 16 (04) :569-577

[6] Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities [J].

Henry, K ;

Melroe, H ;

Huebesch, J ;

Hermundson, J ;

Simpson, J .

LANCET, 1998, 352 (9133) :1031-1032

[7]

Herman RJ, 1999, CAN MED ASSOC J, V161, P1281

[8]

Hsys PH, 2001, ANTIMICROB AGENTS CH, V45, P3445

[9] Drug treatment of lipid disorders [J].

Knopp, RH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :498-511

[10] Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection [J].

Koppel, K ;

Bratt, G ;

Eriksson, M ;

Sandström, E .

INTERNATIONAL JOURNAL OF STD & AIDS, 2000, 11 (07) :451-455

← 1 2 →